NCT01408563View on ClinicalTrials.gov

Reduced Intensity Double Umbilical Cord Blood Transplantation

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Non-Hodgkin's LymphomaHodgkin's LymphomaMultiple MyelomaChronic Lymphocytic LeukemiaAcute Myelogenous Leukemia
Interventions
DRUG

Fludarabine

30 mg/m2/day IV x 6 days

DRUG

Melphalan

100 mg/m2/day IV x 1 day

RADIATION

Total Body Radiation

200 cGy on Day 0

BIOLOGICAL

Cord Blood

2 cord blood units IV

Trial Locations (3)

02114

Massachusetts General Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT01408563 - Reduced Intensity Double Umbilical Cord Blood Transplantation | Biotech Hunter | Biotech Hunter